Not Signed In -
Dermatitis |
Types of dermatitis; Contact Dermatitis; Dermatitis-Atopic Eczema; Dermatitis/Eczema; Rash; Skin Disorders, Dermatitis; Skin Rash; Slide Show: Types of Dermatitis |
Clinical Trial: Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age with Mild or Moderate Atopic Dermatitis
This study is currently recruiting patients.
Verified by Novartis September 2005
|
Purpose
To evaluate the efficacy and safety of pimecrolimus cream 1% in its registered indication (treatment of patients > 3 months of age with mild to moderate atopic dermatitis)
This study is not enrolling patients in the United States.
| Condition | Intervention | Phase |
|---|---|---|
| Atopic Dermatitis | Drug: Pimecrolimus Cream 1% | Phase IV |
MedlinePlus related topics: Allergy; Dermatitis; Genetic Disorders; Skin Conditions
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study
Further Study Details:
Study start: December 2004
Eligibility
Ages Eligible for Study: 3 Months and above, Genders Eligible for Study: Both
Criteria
The patient population must consist of male or female outpatients, age ≥3 months old with mild to moderate atopic dermatitis (IGA ≥ 1). Exclusion criteria are pregnancy, having active viral infections at the site(s) of treatment, presenting with systemic malignancy or active lymphoproliferative diseases/disorders, receiving phototherapy or immunosuppressive therapy, having used tacrolimus ointment and known allergy or hypersensitivity.
Location and Contact Information
Please refer to this study by ClinicalTrials.gov identifier NCT00150059
Novartis Pharma AG + 41 61 324 1111
Philippines
This study is not being conducted in the United States, NA, Philippines; Recruiting
Novartis Pharma AG 41 61 324 1111
Study chairs or principal investigators
Novartis Healthcare Philippines, Study Chair, Novartis
More Information
Study ID Numbers: CASM981CPH01
Last Updated: September 7, 2005
Record first received: September 7, 2005
ClinicalTrials.gov Identifier: NCT00150059
Health Authority: Philippines: Bureau of Food and Drugs
ClinicalTrials.gov processed this record on 2005-09-13
Last Updated: September 7, 2005
Record first received: September 7, 2005
ClinicalTrials.gov Identifier: NCT00150059
Health Authority: Philippines: Bureau of Food and Drugs
ClinicalTrials.gov processed this record on 2005-09-13
email this page
print this page
bookmark this page
feedback on this page
